97 related articles for article (PubMed ID: 2875273)
21. Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.
Swartz ML
Gastroenterol Nurs; 1991; 13(3):158-61. PubMed ID: 1825929
[TBL] [Abstract][Full Text] [Related]
22. Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
Evans DI; Shaw A
BMJ; 1990 Jun; 300(6741):1694-5. PubMed ID: 2143948
[No Abstract] [Full Text] [Related]
23. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
[TBL] [Abstract][Full Text] [Related]
24. Thrombocytopenia reported in association with hepatitis B and A vaccines.
Meyboom RH; Fucik H; Edwards IR
Lancet; 1995 Jun; 345(8965):1638. PubMed ID: 7632294
[No Abstract] [Full Text] [Related]
25. Alleged link between hepatitis B vaccine and chronic fatigue syndrome.
CMAJ; 1992 Jan; 146(1):37-8. PubMed ID: 1530818
[No Abstract] [Full Text] [Related]
26. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
27. [Engerix-B, hepatitis B vaccine produced by means of a recombinant DNA technic].
Ring-Larsen H
Ugeskr Laeger; 1990 Jun; 152(26):1917-9. PubMed ID: 2141959
[No Abstract] [Full Text] [Related]
28. Myasthenia gravis after general anesthesia and hepatitis B vaccine.
Biron P; Montpetit P; Infante-Rivard C; Léry L
Arch Intern Med; 1988 Dec; 148(12):2685. PubMed ID: 2973775
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis A and B vaccines in children.
Lieberman JM; Greenberg DP
Adv Pediatr Infect Dis; 1996; 11():333-63. PubMed ID: 8718466
[No Abstract] [Full Text] [Related]
30. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.
Herroelen L; de Keyser J; Ebinger G
Lancet; 1991 Nov; 338(8776):1174-5. PubMed ID: 1682594
[TBL] [Abstract][Full Text] [Related]
31. Erythema multiforme and hepatitis B immunization.
Milstien JB; Kuritsky JN
Arch Dermatol; 1986 May; 122(5):511-2. PubMed ID: 2939804
[No Abstract] [Full Text] [Related]
32. Hepatitis B immunisation.
Butler H
N Z Med J; 1988 Jul; 101(849):464. PubMed ID: 2969470
[No Abstract] [Full Text] [Related]
33. Uveitis after hepatitis B vaccination.
Fried M; Conen D; Conzelmann M; Steinemann E
Lancet; 1987 Sep; 2(8559):631-2. PubMed ID: 2887922
[No Abstract] [Full Text] [Related]
34. Hepatitis B vaccines--to switch or not to switch.
Hollinger FB
JAMA; 1987 May; 257(19):2634-6. PubMed ID: 2952813
[No Abstract] [Full Text] [Related]
35. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences.
Tron F; Degos F; Bréchot C; Couroucé AM; Goudeau A; Marie FN; Adamowicz P; Saliou P; Laplanche A; Benhamou JP
J Infect Dis; 1989 Aug; 160(2):199-204. PubMed ID: 2527274
[TBL] [Abstract][Full Text] [Related]
36. Vaccines to prevent viral hepatitis.
Lemon SM; Thomas DL
N Engl J Med; 1997 Jan; 336(3):196-204. PubMed ID: 8988900
[No Abstract] [Full Text] [Related]
37. Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis.
Sacks HS; Rose DN; Chalmers TC
JAMA; 1984 Dec; 252(24):3375-7. PubMed ID: 6239044
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B vaccination and AIDS.
Kato S; Iwasaki H; Kimura M; Togo Y
JAMA; 1985 Jul; 254(1):53. PubMed ID: 3158758
[No Abstract] [Full Text] [Related]
39. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
Dahl-Hansen E; Siebke JC; Frøland SS; Degré M
Epidemiol Infect; 1990 Feb; 104(1):143-9. PubMed ID: 2137785
[TBL] [Abstract][Full Text] [Related]
40. [Early diagnosis of occupational allergic dermatoses caused by formaldehyde-containing polymers].
Leonov VA; Somov BA; Zhigulin VA
Vestn Dermatol Venerol; 1978 Dec; (12):6-11. PubMed ID: 154248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]